nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—CYP2E1—prostate cancer	0.193	0.502	CbGaD
Meprobamate—CYP2C19—prostate cancer	0.191	0.498	CbGaD
Meprobamate—CYP2C19—Nilutamide—prostate cancer	0.0446	0.11	CbGbCtD
Meprobamate—CYP2C19—Bicalutamide—prostate cancer	0.0446	0.11	CbGbCtD
Meprobamate—CYP2E1—Estrone—prostate cancer	0.0426	0.105	CbGbCtD
Meprobamate—CYP2C19—Flutamide—prostate cancer	0.037	0.091	CbGbCtD
Meprobamate—ABCB1—Estramustine—prostate cancer	0.0335	0.0824	CbGbCtD
Meprobamate—CYP2E1—Mitoxantrone—prostate cancer	0.0254	0.0625	CbGbCtD
Meprobamate—ABCB1—Cabazitaxel—prostate cancer	0.0221	0.0543	CbGbCtD
Meprobamate—ABCB1—Estrone—prostate cancer	0.0216	0.0531	CbGbCtD
Meprobamate—ABCB1—Ethinyl Estradiol—prostate cancer	0.0192	0.0473	CbGbCtD
Meprobamate—CYP2E1—Etoposide—prostate cancer	0.016	0.0394	CbGbCtD
Meprobamate—CYP2C19—Estradiol—prostate cancer	0.0153	0.0378	CbGbCtD
Meprobamate—ABCB1—Conjugated Estrogens—prostate cancer	0.0141	0.0347	CbGbCtD
Meprobamate—CYP2C19—Prednisone—prostate cancer	0.0132	0.0325	CbGbCtD
Meprobamate—ABCB1—Mitoxantrone—prostate cancer	0.0128	0.0316	CbGbCtD
Meprobamate—ABCB1—Estradiol—prostate cancer	0.0124	0.0305	CbGbCtD
Meprobamate—ABCB1—Prednisone—prostate cancer	0.0106	0.0262	CbGbCtD
Meprobamate—ABCB1—Etoposide—prostate cancer	0.00809	0.0199	CbGbCtD
Meprobamate—ABCB1—Docetaxel—prostate cancer	0.0074	0.0182	CbGbCtD
Meprobamate—ABCB1—Doxorubicin—prostate cancer	0.00551	0.0136	CbGbCtD
Meprobamate—Carisoprodol—CYP2C19—prostate cancer	0.00382	1	CrCbGaD
Meprobamate—Hypotension—Conjugated Estrogens—prostate cancer	0.000251	0.00196	CcSEcCtD
Meprobamate—Vomiting—Bicalutamide—prostate cancer	0.000248	0.00194	CcSEcCtD
Meprobamate—Aplastic anaemia—Epirubicin—prostate cancer	0.000245	0.00192	CcSEcCtD
Meprobamate—Dermatitis—Bicalutamide—prostate cancer	0.000245	0.00192	CcSEcCtD
Meprobamate—Headache—Bicalutamide—prostate cancer	0.000244	0.00191	CcSEcCtD
Meprobamate—Agranulocytosis—Etoposide—prostate cancer	0.000243	0.00191	CcSEcCtD
Meprobamate—Paraesthesia—Goserelin—prostate cancer	0.000243	0.00191	CcSEcCtD
Meprobamate—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000242	0.0019	CcSEcCtD
Meprobamate—Agitation—Estradiol—prostate cancer	0.000242	0.0019	CcSEcCtD
Meprobamate—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000241	0.00189	CcSEcCtD
Meprobamate—Somnolence—Goserelin—prostate cancer	0.000241	0.00189	CcSEcCtD
Meprobamate—Angioedema—Estradiol—prostate cancer	0.00024	0.00188	CcSEcCtD
Meprobamate—Bronchospasm—Docetaxel—prostate cancer	0.000239	0.00188	CcSEcCtD
Meprobamate—Somnolence—Conjugated Estrogens—prostate cancer	0.000238	0.00187	CcSEcCtD
Meprobamate—Rash maculo-papular—Epirubicin—prostate cancer	0.000238	0.00186	CcSEcCtD
Meprobamate—Ecchymosis—Epirubicin—prostate cancer	0.000236	0.00185	CcSEcCtD
Meprobamate—Vertigo—Estradiol—prostate cancer	0.000236	0.00185	CcSEcCtD
Meprobamate—Asthenia—Ethinyl Estradiol—prostate cancer	0.000236	0.00185	CcSEcCtD
Meprobamate—Syncope—Estradiol—prostate cancer	0.000236	0.00185	CcSEcCtD
Meprobamate—Pruritus—Ethinyl Estradiol—prostate cancer	0.000233	0.00183	CcSEcCtD
Meprobamate—Palpitations—Estradiol—prostate cancer	0.000232	0.00182	CcSEcCtD
Meprobamate—Bronchospasm—Capecitabine—prostate cancer	0.000232	0.00182	CcSEcCtD
Meprobamate—Nausea—Bicalutamide—prostate cancer	0.000231	0.00181	CcSEcCtD
Meprobamate—Loss of consciousness—Estradiol—prostate cancer	0.000231	0.00181	CcSEcCtD
Meprobamate—Aplastic anaemia—Doxorubicin—prostate cancer	0.000227	0.00178	CcSEcCtD
Meprobamate—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000225	0.00176	CcSEcCtD
Meprobamate—Lymphadenopathy—Epirubicin—prostate cancer	0.000222	0.00174	CcSEcCtD
Meprobamate—Erythema multiforme—Etoposide—prostate cancer	0.000221	0.00174	CcSEcCtD
Meprobamate—Rash maculo-papular—Doxorubicin—prostate cancer	0.00022	0.00172	CcSEcCtD
Meprobamate—Leukopenia—Mitoxantrone—prostate cancer	0.000219	0.00172	CcSEcCtD
Meprobamate—Ecchymosis—Doxorubicin—prostate cancer	0.000219	0.00171	CcSEcCtD
Meprobamate—Dizziness—Ethinyl Estradiol—prostate cancer	0.000218	0.00171	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000215	0.00169	CcSEcCtD
Meprobamate—Anaphylactic shock—Estradiol—prostate cancer	0.000215	0.00168	CcSEcCtD
Meprobamate—Body temperature increased—Goserelin—prostate cancer	0.000214	0.00168	CcSEcCtD
Meprobamate—Vascular purpura—Epirubicin—prostate cancer	0.000212	0.00166	CcSEcCtD
Meprobamate—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000212	0.00166	CcSEcCtD
Meprobamate—Stomatitis—Docetaxel—prostate cancer	0.000211	0.00166	CcSEcCtD
Meprobamate—Shock—Estradiol—prostate cancer	0.000211	0.00166	CcSEcCtD
Meprobamate—Chills—Etoposide—prostate cancer	0.00021	0.00165	CcSEcCtD
Meprobamate—Tachycardia—Estradiol—prostate cancer	0.00021	0.00164	CcSEcCtD
Meprobamate—Vomiting—Ethinyl Estradiol—prostate cancer	0.000209	0.00164	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000208	0.00163	CcSEcCtD
Meprobamate—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000207	0.00162	CcSEcCtD
Meprobamate—Headache—Ethinyl Estradiol—prostate cancer	0.000206	0.00162	CcSEcCtD
Meprobamate—Lymphadenopathy—Doxorubicin—prostate cancer	0.000206	0.00161	CcSEcCtD
Meprobamate—Stomatitis—Capecitabine—prostate cancer	0.000205	0.0016	CcSEcCtD
Meprobamate—Agranulocytosis—Docetaxel—prostate cancer	0.000202	0.00159	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Epirubicin—prostate cancer	0.000201	0.00158	CcSEcCtD
Meprobamate—Anaphylactic shock—Mitoxantrone—prostate cancer	0.0002	0.00157	CcSEcCtD
Meprobamate—Hypersensitivity—Goserelin—prostate cancer	0.0002	0.00156	CcSEcCtD
Meprobamate—Dermatitis bullous—Epirubicin—prostate cancer	0.000199	0.00156	CcSEcCtD
Meprobamate—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000198	0.00155	CcSEcCtD
Meprobamate—Purpura—Epirubicin—prostate cancer	0.000197	0.00154	CcSEcCtD
Meprobamate—Shock—Mitoxantrone—prostate cancer	0.000197	0.00154	CcSEcCtD
Meprobamate—Vascular purpura—Doxorubicin—prostate cancer	0.000196	0.00154	CcSEcCtD
Meprobamate—Agranulocytosis—Capecitabine—prostate cancer	0.000196	0.00154	CcSEcCtD
Meprobamate—Nausea—Ethinyl Estradiol—prostate cancer	0.000195	0.00153	CcSEcCtD
Meprobamate—Tachycardia—Mitoxantrone—prostate cancer	0.000195	0.00153	CcSEcCtD
Meprobamate—Asthenia—Goserelin—prostate cancer	0.000194	0.00152	CcSEcCtD
Meprobamate—Paraesthesia—Estradiol—prostate cancer	0.000193	0.00151	CcSEcCtD
Meprobamate—Asthenia—Conjugated Estrogens—prostate cancer	0.000192	0.00151	CcSEcCtD
Meprobamate—Oedema peripheral—Docetaxel—prostate cancer	0.000192	0.0015	CcSEcCtD
Meprobamate—Pruritus—Goserelin—prostate cancer	0.000192	0.0015	CcSEcCtD
Meprobamate—Somnolence—Estradiol—prostate cancer	0.000191	0.0015	CcSEcCtD
Meprobamate—Pruritus—Conjugated Estrogens—prostate cancer	0.00019	0.00149	CcSEcCtD
Meprobamate—Hypotension—Mitoxantrone—prostate cancer	0.000187	0.00147	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.000186	0.00146	CcSEcCtD
Meprobamate—Oedema peripheral—Capecitabine—prostate cancer	0.000186	0.00146	CcSEcCtD
Meprobamate—Diarrhoea—Goserelin—prostate cancer	0.000185	0.00145	CcSEcCtD
Meprobamate—Erythema multiforme—Docetaxel—prostate cancer	0.000184	0.00144	CcSEcCtD
Meprobamate—Dermatitis bullous—Doxorubicin—prostate cancer	0.000184	0.00144	CcSEcCtD
Meprobamate—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000184	0.00144	CcSEcCtD
Meprobamate—Vertigo—Etoposide—prostate cancer	0.000183	0.00144	CcSEcCtD
Meprobamate—Leukopenia—Etoposide—prostate cancer	0.000183	0.00143	CcSEcCtD
Meprobamate—Purpura—Doxorubicin—prostate cancer	0.000182	0.00143	CcSEcCtD
Meprobamate—Paraesthesia—Mitoxantrone—prostate cancer	0.00018	0.00141	CcSEcCtD
Meprobamate—Loss of consciousness—Etoposide—prostate cancer	0.000179	0.0014	CcSEcCtD
Meprobamate—Dizziness—Goserelin—prostate cancer	0.000179	0.0014	CcSEcCtD
Meprobamate—Ataxia—Epirubicin—prostate cancer	0.000178	0.0014	CcSEcCtD
Meprobamate—Erythema multiforme—Capecitabine—prostate cancer	0.000178	0.0014	CcSEcCtD
Meprobamate—Somnolence—Mitoxantrone—prostate cancer	0.000178	0.00139	CcSEcCtD
Meprobamate—Dizziness—Conjugated Estrogens—prostate cancer	0.000177	0.00139	CcSEcCtD
Meprobamate—Chills—Docetaxel—prostate cancer	0.000175	0.00137	CcSEcCtD
Meprobamate—Arrhythmia—Docetaxel—prostate cancer	0.000174	0.00136	CcSEcCtD
Meprobamate—Vomiting—Goserelin—prostate cancer	0.000172	0.00135	CcSEcCtD
Meprobamate—Dermatitis—Goserelin—prostate cancer	0.000171	0.00134	CcSEcCtD
Meprobamate—Vomiting—Conjugated Estrogens—prostate cancer	0.000171	0.00134	CcSEcCtD
Meprobamate—Body temperature increased—Estradiol—prostate cancer	0.00017	0.00133	CcSEcCtD
Meprobamate—Headache—Goserelin—prostate cancer	0.00017	0.00133	CcSEcCtD
Meprobamate—Chills—Capecitabine—prostate cancer	0.000169	0.00133	CcSEcCtD
Meprobamate—Dermatitis—Conjugated Estrogens—prostate cancer	0.000169	0.00132	CcSEcCtD
Meprobamate—Arrhythmia—Capecitabine—prostate cancer	0.000168	0.00132	CcSEcCtD
Meprobamate—Headache—Conjugated Estrogens—prostate cancer	0.000168	0.00132	CcSEcCtD
Meprobamate—Anaphylactic shock—Etoposide—prostate cancer	0.000166	0.0013	CcSEcCtD
Meprobamate—Ataxia—Doxorubicin—prostate cancer	0.000165	0.00129	CcSEcCtD
Meprobamate—Tachycardia—Etoposide—prostate cancer	0.000162	0.00127	CcSEcCtD
Meprobamate—Eosinophilia—Epirubicin—prostate cancer	0.000162	0.00127	CcSEcCtD
Meprobamate—Nausea—Goserelin—prostate cancer	0.000161	0.00126	CcSEcCtD
Meprobamate—Nausea—Conjugated Estrogens—prostate cancer	0.000159	0.00125	CcSEcCtD
Meprobamate—Hypersensitivity—Estradiol—prostate cancer	0.000158	0.00124	CcSEcCtD
Meprobamate—Body temperature increased—Mitoxantrone—prostate cancer	0.000158	0.00124	CcSEcCtD
Meprobamate—Hypotension—Etoposide—prostate cancer	0.000155	0.00122	CcSEcCtD
Meprobamate—Asthenia—Estradiol—prostate cancer	0.000154	0.00121	CcSEcCtD
Meprobamate—Syncope—Docetaxel—prostate cancer	0.000152	0.00119	CcSEcCtD
Meprobamate—Pruritus—Estradiol—prostate cancer	0.000152	0.00119	CcSEcCtD
Meprobamate—Leukopenia—Docetaxel—prostate cancer	0.000152	0.00119	CcSEcCtD
Meprobamate—Eosinophilia—Doxorubicin—prostate cancer	0.00015	0.00118	CcSEcCtD
Meprobamate—Arrhythmia—Prednisone—prostate cancer	0.00015	0.00118	CcSEcCtD
Meprobamate—Palpitations—Docetaxel—prostate cancer	0.00015	0.00117	CcSEcCtD
Meprobamate—Paraesthesia—Etoposide—prostate cancer	0.000149	0.00117	CcSEcCtD
Meprobamate—Loss of consciousness—Docetaxel—prostate cancer	0.000149	0.00117	CcSEcCtD
Meprobamate—Somnolence—Etoposide—prostate cancer	0.000148	0.00116	CcSEcCtD
Meprobamate—Vertigo—Capecitabine—prostate cancer	0.000147	0.00116	CcSEcCtD
Meprobamate—Hypersensitivity—Mitoxantrone—prostate cancer	0.000147	0.00116	CcSEcCtD
Meprobamate—Syncope—Capecitabine—prostate cancer	0.000147	0.00115	CcSEcCtD
Meprobamate—Diarrhoea—Estradiol—prostate cancer	0.000147	0.00115	CcSEcCtD
Meprobamate—Leukopenia—Capecitabine—prostate cancer	0.000147	0.00115	CcSEcCtD
Meprobamate—Drowsiness—Epirubicin—prostate cancer	0.000146	0.00115	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000145	0.00114	CcSEcCtD
Meprobamate—Palpitations—Capecitabine—prostate cancer	0.000145	0.00114	CcSEcCtD
Meprobamate—Loss of consciousness—Capecitabine—prostate cancer	0.000144	0.00113	CcSEcCtD
Meprobamate—Asthenia—Mitoxantrone—prostate cancer	0.000144	0.00113	CcSEcCtD
Meprobamate—Stomatitis—Epirubicin—prostate cancer	0.000143	0.00112	CcSEcCtD
Meprobamate—Dizziness—Estradiol—prostate cancer	0.000142	0.00111	CcSEcCtD
Meprobamate—Anaphylactic shock—Docetaxel—prostate cancer	0.000138	0.00108	CcSEcCtD
Meprobamate—Diarrhoea—Mitoxantrone—prostate cancer	0.000137	0.00107	CcSEcCtD
Meprobamate—Vomiting—Estradiol—prostate cancer	0.000137	0.00107	CcSEcCtD
Meprobamate—Agranulocytosis—Epirubicin—prostate cancer	0.000136	0.00107	CcSEcCtD
Meprobamate—Shock—Docetaxel—prostate cancer	0.000136	0.00107	CcSEcCtD
Meprobamate—Drowsiness—Doxorubicin—prostate cancer	0.000135	0.00106	CcSEcCtD
Meprobamate—Dermatitis—Estradiol—prostate cancer	0.000135	0.00106	CcSEcCtD
Meprobamate—Tachycardia—Docetaxel—prostate cancer	0.000135	0.00106	CcSEcCtD
Meprobamate—Headache—Estradiol—prostate cancer	0.000135	0.00105	CcSEcCtD
Meprobamate—Agitation—Prednisone—prostate cancer	0.000134	0.00105	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000134	0.00105	CcSEcCtD
Meprobamate—Angioedema—Prednisone—prostate cancer	0.000134	0.00105	CcSEcCtD
Meprobamate—Stomatitis—Doxorubicin—prostate cancer	0.000132	0.00103	CcSEcCtD
Meprobamate—Shock—Capecitabine—prostate cancer	0.000132	0.00103	CcSEcCtD
Meprobamate—Body temperature increased—Etoposide—prostate cancer	0.000132	0.00103	CcSEcCtD
Meprobamate—Vertigo—Prednisone—prostate cancer	0.000131	0.00103	CcSEcCtD
Meprobamate—Syncope—Prednisone—prostate cancer	0.000131	0.00103	CcSEcCtD
Meprobamate—Tachycardia—Capecitabine—prostate cancer	0.000131	0.00102	CcSEcCtD
Meprobamate—Oedema peripheral—Epirubicin—prostate cancer	0.000129	0.00101	CcSEcCtD
Meprobamate—Hypotension—Docetaxel—prostate cancer	0.000129	0.00101	CcSEcCtD
Meprobamate—Loss of consciousness—Prednisone—prostate cancer	0.000128	0.00101	CcSEcCtD
Meprobamate—Nausea—Estradiol—prostate cancer	0.000128	0.001	CcSEcCtD
Meprobamate—Vomiting—Mitoxantrone—prostate cancer	0.000127	0.000997	CcSEcCtD
Meprobamate—Agranulocytosis—Doxorubicin—prostate cancer	0.000126	0.00099	CcSEcCtD
Meprobamate—Dermatitis—Mitoxantrone—prostate cancer	0.000126	0.000988	CcSEcCtD
Meprobamate—Headache—Mitoxantrone—prostate cancer	0.000125	0.000982	CcSEcCtD
Meprobamate—Hypotension—Capecitabine—prostate cancer	0.000125	0.000981	CcSEcCtD
Meprobamate—Paraesthesia—Docetaxel—prostate cancer	0.000124	0.000973	CcSEcCtD
Meprobamate—Erythema multiforme—Epirubicin—prostate cancer	0.000124	0.000973	CcSEcCtD
Meprobamate—Somnolence—Docetaxel—prostate cancer	0.000123	0.000964	CcSEcCtD
Meprobamate—Hypersensitivity—Etoposide—prostate cancer	0.000123	0.000961	CcSEcCtD
Meprobamate—Paraesthesia—Capecitabine—prostate cancer	0.00012	0.000942	CcSEcCtD
Meprobamate—Oedema peripheral—Doxorubicin—prostate cancer	0.00012	0.000938	CcSEcCtD
Meprobamate—Asthenia—Etoposide—prostate cancer	0.000119	0.000936	CcSEcCtD
Meprobamate—Anaphylactic shock—Prednisone—prostate cancer	0.000119	0.000935	CcSEcCtD
Meprobamate—Nausea—Mitoxantrone—prostate cancer	0.000119	0.000931	CcSEcCtD
Meprobamate—Chills—Epirubicin—prostate cancer	0.000118	0.000923	CcSEcCtD
Meprobamate—Pruritus—Etoposide—prostate cancer	0.000118	0.000923	CcSEcCtD
Meprobamate—Shock—Prednisone—prostate cancer	0.000117	0.00092	CcSEcCtD
Meprobamate—Arrhythmia—Epirubicin—prostate cancer	0.000117	0.000919	CcSEcCtD
Meprobamate—Tachycardia—Prednisone—prostate cancer	0.000116	0.000912	CcSEcCtD
Meprobamate—Erythema multiforme—Doxorubicin—prostate cancer	0.000115	0.0009	CcSEcCtD
Meprobamate—Diarrhoea—Etoposide—prostate cancer	0.000114	0.000892	CcSEcCtD
Meprobamate—Dizziness—Etoposide—prostate cancer	0.00011	0.000863	CcSEcCtD
Meprobamate—Body temperature increased—Docetaxel—prostate cancer	0.000109	0.000857	CcSEcCtD
Meprobamate—Chills—Doxorubicin—prostate cancer	0.000109	0.000854	CcSEcCtD
Meprobamate—Arrhythmia—Doxorubicin—prostate cancer	0.000109	0.000851	CcSEcCtD
Meprobamate—Paraesthesia—Prednisone—prostate cancer	0.000107	0.000839	CcSEcCtD
Meprobamate—Body temperature increased—Capecitabine—prostate cancer	0.000106	0.00083	CcSEcCtD
Meprobamate—Vomiting—Etoposide—prostate cancer	0.000106	0.000829	CcSEcCtD
Meprobamate—Agitation—Epirubicin—prostate cancer	0.000105	0.000823	CcSEcCtD
Meprobamate—Dermatitis—Etoposide—prostate cancer	0.000105	0.000822	CcSEcCtD
Meprobamate—Headache—Etoposide—prostate cancer	0.000104	0.000817	CcSEcCtD
Meprobamate—Vertigo—Epirubicin—prostate cancer	0.000103	0.000805	CcSEcCtD
Meprobamate—Syncope—Epirubicin—prostate cancer	0.000102	0.000803	CcSEcCtD
Meprobamate—Leukopenia—Epirubicin—prostate cancer	0.000102	0.000802	CcSEcCtD
Meprobamate—Hypersensitivity—Docetaxel—prostate cancer	0.000102	0.000799	CcSEcCtD
Meprobamate—Palpitations—Epirubicin—prostate cancer	0.000101	0.000792	CcSEcCtD
Meprobamate—Loss of consciousness—Epirubicin—prostate cancer	0.0001	0.000787	CcSEcCtD
Meprobamate—Asthenia—Docetaxel—prostate cancer	9.92e-05	0.000778	CcSEcCtD
Meprobamate—Nausea—Etoposide—prostate cancer	9.88e-05	0.000775	CcSEcCtD
Meprobamate—Hypersensitivity—Capecitabine—prostate cancer	9.86e-05	0.000773	CcSEcCtD
Meprobamate—Pruritus—Docetaxel—prostate cancer	9.78e-05	0.000767	CcSEcCtD
Meprobamate—Agitation—Doxorubicin—prostate cancer	9.72e-05	0.000762	CcSEcCtD
Meprobamate—Asthenia—Capecitabine—prostate cancer	9.61e-05	0.000753	CcSEcCtD
Meprobamate—Vertigo—Doxorubicin—prostate cancer	9.5e-05	0.000745	CcSEcCtD
Meprobamate—Syncope—Doxorubicin—prostate cancer	9.48e-05	0.000743	CcSEcCtD
Meprobamate—Pruritus—Capecitabine—prostate cancer	9.47e-05	0.000743	CcSEcCtD
Meprobamate—Leukopenia—Doxorubicin—prostate cancer	9.47e-05	0.000742	CcSEcCtD
Meprobamate—Diarrhoea—Docetaxel—prostate cancer	9.46e-05	0.000742	CcSEcCtD
Meprobamate—Body temperature increased—Prednisone—prostate cancer	9.43e-05	0.000739	CcSEcCtD
Meprobamate—Palpitations—Doxorubicin—prostate cancer	9.35e-05	0.000733	CcSEcCtD
Meprobamate—Anaphylactic shock—Epirubicin—prostate cancer	9.33e-05	0.000731	CcSEcCtD
Meprobamate—Loss of consciousness—Doxorubicin—prostate cancer	9.29e-05	0.000729	CcSEcCtD
Meprobamate—Shock—Epirubicin—prostate cancer	9.18e-05	0.000719	CcSEcCtD
Meprobamate—Diarrhoea—Capecitabine—prostate cancer	9.16e-05	0.000718	CcSEcCtD
Meprobamate—Dizziness—Docetaxel—prostate cancer	9.14e-05	0.000717	CcSEcCtD
Meprobamate—Tachycardia—Epirubicin—prostate cancer	9.1e-05	0.000714	CcSEcCtD
Meprobamate—Dizziness—Capecitabine—prostate cancer	8.85e-05	0.000694	CcSEcCtD
Meprobamate—Vomiting—Docetaxel—prostate cancer	8.79e-05	0.000689	CcSEcCtD
Meprobamate—Hypersensitivity—Prednisone—prostate cancer	8.79e-05	0.000689	CcSEcCtD
Meprobamate—Hypotension—Epirubicin—prostate cancer	8.72e-05	0.000683	CcSEcCtD
Meprobamate—Dermatitis—Docetaxel—prostate cancer	8.71e-05	0.000683	CcSEcCtD
Meprobamate—Headache—Docetaxel—prostate cancer	8.66e-05	0.000679	CcSEcCtD
Meprobamate—Anaphylactic shock—Doxorubicin—prostate cancer	8.63e-05	0.000677	CcSEcCtD
Meprobamate—Asthenia—Prednisone—prostate cancer	8.56e-05	0.000671	CcSEcCtD
Meprobamate—Vomiting—Capecitabine—prostate cancer	8.51e-05	0.000667	CcSEcCtD
Meprobamate—Shock—Doxorubicin—prostate cancer	8.49e-05	0.000666	CcSEcCtD
Meprobamate—Pruritus—Prednisone—prostate cancer	8.44e-05	0.000661	CcSEcCtD
Meprobamate—Dermatitis—Capecitabine—prostate cancer	8.43e-05	0.000661	CcSEcCtD
Meprobamate—Tachycardia—Doxorubicin—prostate cancer	8.42e-05	0.00066	CcSEcCtD
Meprobamate—Headache—Capecitabine—prostate cancer	8.39e-05	0.000657	CcSEcCtD
Meprobamate—Paraesthesia—Epirubicin—prostate cancer	8.38e-05	0.000657	CcSEcCtD
Meprobamate—Somnolence—Epirubicin—prostate cancer	8.29e-05	0.00065	CcSEcCtD
Meprobamate—Nausea—Docetaxel—prostate cancer	8.21e-05	0.000644	CcSEcCtD
Meprobamate—Diarrhoea—Prednisone—prostate cancer	8.16e-05	0.00064	CcSEcCtD
Meprobamate—Hypotension—Doxorubicin—prostate cancer	8.06e-05	0.000632	CcSEcCtD
Meprobamate—Nausea—Capecitabine—prostate cancer	7.95e-05	0.000623	CcSEcCtD
Meprobamate—Dizziness—Prednisone—prostate cancer	7.89e-05	0.000618	CcSEcCtD
Meprobamate—Paraesthesia—Doxorubicin—prostate cancer	7.75e-05	0.000607	CcSEcCtD
Meprobamate—Somnolence—Doxorubicin—prostate cancer	7.67e-05	0.000601	CcSEcCtD
Meprobamate—Vomiting—Prednisone—prostate cancer	7.58e-05	0.000594	CcSEcCtD
Meprobamate—Dermatitis—Prednisone—prostate cancer	7.51e-05	0.000589	CcSEcCtD
Meprobamate—Headache—Prednisone—prostate cancer	7.47e-05	0.000586	CcSEcCtD
Meprobamate—Body temperature increased—Epirubicin—prostate cancer	7.37e-05	0.000578	CcSEcCtD
Meprobamate—Nausea—Prednisone—prostate cancer	7.08e-05	0.000555	CcSEcCtD
Meprobamate—Hypersensitivity—Epirubicin—prostate cancer	6.87e-05	0.000539	CcSEcCtD
Meprobamate—Body temperature increased—Doxorubicin—prostate cancer	6.82e-05	0.000535	CcSEcCtD
Meprobamate—Asthenia—Epirubicin—prostate cancer	6.69e-05	0.000525	CcSEcCtD
Meprobamate—Pruritus—Epirubicin—prostate cancer	6.6e-05	0.000517	CcSEcCtD
Meprobamate—Diarrhoea—Epirubicin—prostate cancer	6.38e-05	0.0005	CcSEcCtD
Meprobamate—Hypersensitivity—Doxorubicin—prostate cancer	6.36e-05	0.000498	CcSEcCtD
Meprobamate—Asthenia—Doxorubicin—prostate cancer	6.19e-05	0.000485	CcSEcCtD
Meprobamate—Dizziness—Epirubicin—prostate cancer	6.17e-05	0.000484	CcSEcCtD
Meprobamate—Pruritus—Doxorubicin—prostate cancer	6.11e-05	0.000479	CcSEcCtD
Meprobamate—Vomiting—Epirubicin—prostate cancer	5.93e-05	0.000465	CcSEcCtD
Meprobamate—Diarrhoea—Doxorubicin—prostate cancer	5.91e-05	0.000463	CcSEcCtD
Meprobamate—Dermatitis—Epirubicin—prostate cancer	5.88e-05	0.000461	CcSEcCtD
Meprobamate—Headache—Epirubicin—prostate cancer	5.84e-05	0.000458	CcSEcCtD
Meprobamate—Dizziness—Doxorubicin—prostate cancer	5.71e-05	0.000447	CcSEcCtD
Meprobamate—Nausea—Epirubicin—prostate cancer	5.54e-05	0.000434	CcSEcCtD
Meprobamate—Vomiting—Doxorubicin—prostate cancer	5.49e-05	0.00043	CcSEcCtD
Meprobamate—Dermatitis—Doxorubicin—prostate cancer	5.44e-05	0.000426	CcSEcCtD
Meprobamate—Headache—Doxorubicin—prostate cancer	5.41e-05	0.000424	CcSEcCtD
Meprobamate—Nausea—Doxorubicin—prostate cancer	5.13e-05	0.000402	CcSEcCtD
Meprobamate—CYP2E1—Metabolism—SLC22A3—prostate cancer	1.17e-05	0.000147	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.14e-05	0.000144	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP7B1—prostate cancer	1.14e-05	0.000143	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—MTAP—prostate cancer	1.14e-05	0.000143	CbGpPWpGaD
Meprobamate—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.13e-05	0.000142	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTA4—prostate cancer	1.12e-05	0.000141	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—TBXAS1—prostate cancer	1.12e-05	0.000141	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.11e-05	0.00014	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.11e-05	0.00014	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MTAP—prostate cancer	1.11e-05	0.00014	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP7B1—prostate cancer	1.11e-05	0.00014	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.11e-05	0.00014	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SULT1E1—prostate cancer	1.11e-05	0.000139	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SRD5A1—prostate cancer	1.11e-05	0.000139	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTA2—prostate cancer	1.09e-05	0.000137	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.09e-05	0.000137	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SULT1E1—prostate cancer	1.08e-05	0.000136	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SRD5A1—prostate cancer	1.08e-05	0.000136	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.08e-05	0.000135	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ABCG5—prostate cancer	1.08e-05	0.000135	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SULT1A1—prostate cancer	1.08e-05	0.000135	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.06e-05	0.000133	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.06e-05	0.000133	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HSD17B3—prostate cancer	1.06e-05	0.000133	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ACSL4—prostate cancer	1.06e-05	0.000133	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTA1—prostate cancer	1.05e-05	0.000132	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.05e-05	0.000132	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.05e-05	0.000131	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NAT2—prostate cancer	1.04e-05	0.000131	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HSD3B2—prostate cancer	1.04e-05	0.000131	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTO1—prostate cancer	1.04e-05	0.000131	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HSD17B3—prostate cancer	1.03e-05	0.00013	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ACSL4—prostate cancer	1.03e-05	0.00013	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.02e-05	0.000129	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.02e-05	0.000128	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PHGDH—prostate cancer	1.01e-05	0.000128	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ARG2—prostate cancer	1.01e-05	0.000128	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—UMPS—prostate cancer	1.01e-05	0.000128	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.01e-05	0.000127	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PLCB2—prostate cancer	9.96e-06	0.000125	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP2C18—prostate cancer	9.96e-06	0.000125	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—LRP2—prostate cancer	9.96e-06	0.000125	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—LDHB—prostate cancer	9.95e-06	0.000125	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ARG2—prostate cancer	9.9e-06	0.000124	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—UMPS—prostate cancer	9.9e-06	0.000124	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PHGDH—prostate cancer	9.9e-06	0.000124	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	9.85e-06	0.000124	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—P4HB—prostate cancer	9.77e-06	0.000123	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP3A5—prostate cancer	9.76e-06	0.000123	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	9.75e-06	0.000123	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—LDHB—prostate cancer	9.71e-06	0.000122	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP3A5—prostate cancer	9.53e-06	0.00012	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC22A1—prostate cancer	9.51e-06	0.00012	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	9.48e-06	0.000119	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—TCN2—prostate cancer	9.43e-06	0.000119	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—UCP3—prostate cancer	9.43e-06	0.000119	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PDHA1—prostate cancer	9.43e-06	0.000119	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTA3—prostate cancer	9.43e-06	0.000119	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	9.37e-06	0.000118	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SULT2A1—prostate cancer	9.26e-06	0.000116	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	9.23e-06	0.000116	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—UCP3—prostate cancer	9.2e-06	0.000116	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TCN2—prostate cancer	9.2e-06	0.000116	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PDHA1—prostate cancer	9.2e-06	0.000116	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTA3—prostate cancer	9.2e-06	0.000116	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—MED12—prostate cancer	9.11e-06	0.000115	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GNG5—prostate cancer	9.04e-06	0.000114	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC22A3—prostate cancer	9e-06	0.000113	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HSD3B1—prostate cancer	9e-06	0.000113	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC22A3—prostate cancer	8.78e-06	0.00011	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HSD3B1—prostate cancer	8.78e-06	0.00011	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	8.73e-06	0.00011	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NCOA3—prostate cancer	8.71e-06	0.00011	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTA4—prostate cancer	8.63e-06	0.000108	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—TBXAS1—prostate cancer	8.63e-06	0.000108	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	8.49e-06	0.000107	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	8.47e-06	0.000107	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	8.43e-06	0.000106	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TBXAS1—prostate cancer	8.42e-06	0.000106	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTA4—prostate cancer	8.42e-06	0.000106	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTA2—prostate cancer	8.41e-06	0.000106	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—HPGDS—prostate cancer	8.31e-06	0.000104	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	8.31e-06	0.000104	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ABCG5—prostate cancer	8.3e-06	0.000104	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SULT1A1—prostate cancer	8.3e-06	0.000104	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP2C19—prostate cancer	8.26e-06	0.000104	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTA2—prostate cancer	8.2e-06	0.000103	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTA1—prostate cancer	8.11e-06	0.000102	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ABCG5—prostate cancer	8.1e-06	0.000102	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SULT1A1—prostate cancer	8.1e-06	0.000102	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTT1—prostate cancer	8.06e-06	0.000101	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ACHE—prostate cancer	8.06e-06	0.000101	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NAT2—prostate cancer	8.02e-06	0.000101	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTO1—prostate cancer	8.02e-06	0.000101	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HSD3B2—prostate cancer	8.02e-06	0.000101	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP2A6—prostate cancer	7.97e-06	0.0001	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTA1—prostate cancer	7.92e-06	9.95e-05	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	7.85e-06	9.87e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HSD3B2—prostate cancer	7.83e-06	9.84e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NAT2—prostate cancer	7.83e-06	9.84e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTO1—prostate cancer	7.83e-06	9.84e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—AKR1C3—prostate cancer	7.75e-06	9.74e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.71e-06	9.69e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PRKACB—prostate cancer	7.71e-06	9.69e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PLCB2—prostate cancer	7.69e-06	9.67e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP2C18—prostate cancer	7.69e-06	9.67e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—LRP2—prostate cancer	7.69e-06	9.67e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP17A1—prostate cancer	7.63e-06	9.59e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—P4HB—prostate cancer	7.54e-06	9.48e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—LRP2—prostate cancer	7.5e-06	9.43e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PLCB2—prostate cancer	7.5e-06	9.43e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP2C18—prostate cancer	7.5e-06	9.43e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—P4HB—prostate cancer	7.36e-06	9.25e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC22A1—prostate cancer	7.33e-06	9.22e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NCOA2—prostate cancer	7.27e-06	9.14e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.25e-06	9.11e-05	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	7.21e-06	9.06e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC22A1—prostate cancer	7.16e-06	9e-05	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	7.16e-06	9e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SULT2A1—prostate cancer	7.15e-06	8.99e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—MED12—prostate cancer	7.03e-06	8.84e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SULT2A1—prostate cancer	6.98e-06	8.77e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GNG5—prostate cancer	6.98e-06	8.77e-05	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	6.97e-06	8.77e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—SLC5A5—prostate cancer	6.93e-06	8.72e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MED12—prostate cancer	6.86e-06	8.63e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GNG5—prostate cancer	6.81e-06	8.56e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NCOA3—prostate cancer	6.72e-06	8.45e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NQO1—prostate cancer	6.7e-06	8.42e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.6e-06	8.3e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—TH—prostate cancer	6.6e-06	8.3e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NCOA3—prostate cancer	6.56e-06	8.25e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP3A4—prostate cancer	6.53e-06	8.21e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP1B1—prostate cancer	6.42e-06	8.07e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—HPGDS—prostate cancer	6.41e-06	8.06e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—HPGDS—prostate cancer	6.26e-06	7.87e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GGT1—prostate cancer	6.22e-06	7.82e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ACHE—prostate cancer	6.22e-06	7.82e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP2C19—prostate cancer	6.22e-06	7.82e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTT1—prostate cancer	6.22e-06	7.82e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP2A6—prostate cancer	6.15e-06	7.73e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NCOA1—prostate cancer	6.13e-06	7.7e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.12e-06	7.7e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTT1—prostate cancer	6.07e-06	7.63e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ACHE—prostate cancer	6.07e-06	7.63e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP19A1—prostate cancer	6.04e-06	7.59e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP2A6—prostate cancer	6e-06	7.54e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—AKR1C3—prostate cancer	5.98e-06	7.52e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PRKACB—prostate cancer	5.95e-06	7.48e-05	CbGpPWpGaD
Meprobamate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	5.89e-06	7.4e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP17A1—prostate cancer	5.89e-06	7.4e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—AKR1C3—prostate cancer	5.84e-06	7.34e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—RXRA—prostate cancer	5.83e-06	7.33e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.8e-06	7.3e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PRKACB—prostate cancer	5.8e-06	7.3e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP17A1—prostate cancer	5.74e-06	7.22e-05	CbGpPWpGaD
Meprobamate—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.68e-06	7.14e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—COMT—prostate cancer	5.61e-06	7.06e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NCOA2—prostate cancer	5.61e-06	7.05e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTP1—prostate cancer	5.59e-06	7.02e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ITPR1—prostate cancer	5.5e-06	6.91e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NCOA2—prostate cancer	5.47e-06	6.88e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—SLC5A5—prostate cancer	5.35e-06	6.73e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP2E1—prostate cancer	5.23e-06	6.57e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—SLC5A5—prostate cancer	5.22e-06	6.57e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—TYMS—prostate cancer	5.19e-06	6.53e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NQO1—prostate cancer	5.17e-06	6.5e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—GSTM1—prostate cancer	5.13e-06	6.45e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP2E1—prostate cancer	5.1e-06	6.41e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—TH—prostate cancer	5.09e-06	6.4e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.06e-06	6.36e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NQO1—prostate cancer	5.04e-06	6.34e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP3A4—prostate cancer	5.04e-06	6.34e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—LPL—prostate cancer	5.04e-06	6.33e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.01e-06	6.3e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TH—prostate cancer	4.97e-06	6.25e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP1B1—prostate cancer	4.95e-06	6.23e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP3A4—prostate cancer	4.92e-06	6.18e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CYP1A1—prostate cancer	4.87e-06	6.12e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP1B1—prostate cancer	4.84e-06	6.08e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—ERCC2—prostate cancer	4.83e-06	6.07e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GGT1—prostate cancer	4.8e-06	6.03e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NCOA1—prostate cancer	4.73e-06	5.94e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GGT1—prostate cancer	4.68e-06	5.89e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.66e-06	5.86e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NCOA1—prostate cancer	4.61e-06	5.8e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP19A1—prostate cancer	4.55e-06	5.72e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—MTHFR—prostate cancer	4.54e-06	5.7e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—RXRA—prostate cancer	4.5e-06	5.65e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PPARA—prostate cancer	4.45e-06	5.6e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—RXRA—prostate cancer	4.39e-06	5.52e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.37e-06	5.5e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—COMT—prostate cancer	4.33e-06	5.44e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTP1—prostate cancer	4.31e-06	5.42e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ITPR1—prostate cancer	4.24e-06	5.33e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—COMT—prostate cancer	4.23e-06	5.31e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTP1—prostate cancer	4.21e-06	5.29e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CAV1—prostate cancer	4.18e-06	5.26e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.17e-06	5.24e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ITPR1—prostate cancer	4.14e-06	5.2e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—TYMS—prostate cancer	4.01e-06	5.04e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—GSTM1—prostate cancer	3.96e-06	4.98e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—TYMS—prostate cancer	3.91e-06	4.92e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—LPL—prostate cancer	3.89e-06	4.89e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—GSTM1—prostate cancer	3.87e-06	4.86e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3CG—prostate cancer	3.81e-06	4.79e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—LPL—prostate cancer	3.79e-06	4.77e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.75e-06	4.72e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—ERCC2—prostate cancer	3.72e-06	4.68e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CYP1A1—prostate cancer	3.66e-06	4.61e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—ERCC2—prostate cancer	3.63e-06	4.57e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—INS—prostate cancer	3.61e-06	4.54e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—CREBBP—prostate cancer	3.53e-06	4.44e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—MTHFR—prostate cancer	3.5e-06	4.4e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PPARA—prostate cancer	3.43e-06	4.32e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—MTHFR—prostate cancer	3.42e-06	4.3e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PPARA—prostate cancer	3.35e-06	4.21e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3CD—prostate cancer	3.35e-06	4.21e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CAV1—prostate cancer	3.23e-06	4.06e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—NOS3—prostate cancer	3.16e-06	3.98e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CAV1—prostate cancer	3.15e-06	3.96e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.08e-06	3.88e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.94e-06	3.7e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3CB—prostate cancer	2.92e-06	3.67e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTGS2—prostate cancer	2.89e-06	3.64e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3CG—prostate cancer	2.87e-06	3.61e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—INS—prostate cancer	2.78e-06	3.5e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—CREBBP—prostate cancer	2.73e-06	3.43e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—INS—prostate cancer	2.72e-06	3.42e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—CREBBP—prostate cancer	2.66e-06	3.35e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.59e-06	3.25e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PTEN—prostate cancer	2.52e-06	3.17e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3CD—prostate cancer	2.52e-06	3.17e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—NOS3—prostate cancer	2.44e-06	3.07e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—EP300—prostate cancer	2.41e-06	3.03e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—NOS3—prostate cancer	2.38e-06	3e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.25e-06	2.83e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTGS2—prostate cancer	2.23e-06	2.81e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3CB—prostate cancer	2.2e-06	2.77e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTGS2—prostate cancer	2.18e-06	2.74e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PTEN—prostate cancer	1.95e-06	2.45e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PTEN—prostate cancer	1.9e-06	2.39e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—EP300—prostate cancer	1.86e-06	2.33e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—EP300—prostate cancer	1.81e-06	2.28e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.78e-06	2.24e-05	CbGpPWpGaD
Meprobamate—CYP2E1—Metabolism—AKT1—prostate cancer	1.45e-06	1.83e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.37e-06	1.73e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—PIK3CA—prostate cancer	1.34e-06	1.69e-05	CbGpPWpGaD
Meprobamate—CYP2C19—Metabolism—AKT1—prostate cancer	1.12e-06	1.41e-05	CbGpPWpGaD
Meprobamate—ABCB1—Metabolism—AKT1—prostate cancer	1.1e-06	1.38e-05	CbGpPWpGaD
